Many GLP-1 ads dominated the Super Bowl airwaves, including Ro (featuring an appearance by Serena Williams), Wegovy (with an appearance by Kenan Thompson) and others
Our powerful probiotics, enzymes and supplements are designed to promote gut health and comfort, healthy digestive function and immune system support
How does FDA's 2026 action affect compounded GLP-1 programs
The share of the public who report having heard about these drugs has increased since July 2023 when seven in ten adults reported having heard at least a little about these drugs and one in five (19%) said they had heard a lot. The share who say they have heard a lot about these drugs rises to at least four in ten among those who have ever been told by a doctor that they have diabetes (45%) or heart disease (41%) or have been told by a doctor in the past five years that they are overweight or obese (42%) the primary conditions these drugs are prescribed for
Sustain results after GLP-1s with Virtas nutrition therapy that addresses the root cause of obesity and unhealthy weight A proven approach for deprescribing GLP-1s when clinically appropriate Our first of its kind research study shows sustained weight loss after deprescribing GLP-1s among a real world population
It should be mentioned that some gliptins, like linagliptin and saxagliptin may be metabolized via the CYP3A4 or CYP3A4/5 pathways, and this could result in a diminished clearance of other drugs using the same pathways
